11th Circ. Asked To Revive Fraud Claims Over Chinese Pharma

By Nathan Hale (November 21, 2014, 7:55 PM EST) -- Investors in a putative class action against Chinese drugmaker Jiangbo Pharmaceuticals Inc. argued Friday in Miami that the Eleventh Circuit should reverse a lower court's dismissal of their case against the company's former chief financial officer and former auditing firm for failure to adequately plead their claims....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!